Table IV.
Overall survival
| OS univariate | |||
|---|---|---|---|
| Characteristics | HR1 | 95% CI 1 | p-value |
| Age | 1.02 | 1.00, 1.04 | 0.027 |
| PBSC | 6.80 | 1.60, 28.9 | 0.009 |
| Sorror as continuous | 1.44 | 1.13, 1.83 | 0.003 |
| CyA+MTX | 6.01 | 1.36, 26.5 | 0.018 |
| OS multivariate | |||
| Characteristics | HR 1 | 95% CI 1 | p-value |
| Sorror_n | 1.33 | 1.04, 1.70 | 0.022 |
| HSC source (PBSC) | 5.17 | 1.20, 22.3 | 0.027 |
1HR: hazard ratio; CI: confidence interval.
All variables analyzed: age, median (range); aGvHD, No. (%); anti-HLA Ab, No. (%); bacterial infections, No. (%); CD3+, median (range); CD34+, median (range); conditioning regimen, No. (%); diagnosis, No. (%), donor, No. (%); donor age, median (range); donor gender, No. (%); DSA, No. (%); fungal infections, No. (%); graft manipulation, No. (%); GvHD prophylaxis, No. (%); HLA match, No. (%); ABO match, No. (%); HSC source, No. (%); pregnancies, No. (%); pre-HSCT blood transfusions, No. (%); Sorror, No. (%); viral infections, No. (%).